Experienced in Tuberous Sclerosis Complex

Roman-ulrich D. Muller

Joseph Stelzmann Str. 26, 
Koeln, NW, DE 
Experienced in Tuberous Sclerosis Complex
Joseph Stelzmann Str. 26, 
Koeln, NW, DE 
OverviewLocationsClinical Research

Overview

Roman-ulrich Muller practices in Koeln, Germany. Muller is rated as an Experienced expert by MediFind in the treatment of Tuberous Sclerosis Complex. Their top areas of expertise are Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, Autosomal Recessive Polycystic Kidney Disease, Kidney Transplant, and Nephrectomy.

Their clinical research consists of co-authoring 151 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Tuberous Sclerosis Complex.

Locations

Joseph Stelzmann Str. 26, Koeln, NW 50931, Germany
Other Locations
Kerpener Str. 37, Koeln, NW 50937, Germany
Kerpener Str. 62, Koeln, NW 50937, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome
Enrollment Status: Terminated
Publish Date: September 11, 2025
Intervention Type: Drug
Study Drug: Iademirsen
Study Phase: Phase 2

151 Total Publications

The WHO Classification of Renal Cell Tumours: Implications for Personalised Treatment Decisions and Accurate Detection of Hereditary Renal Cell Carcinomas
The WHO Classification of Renal Cell Tumours: Implications for Personalised Treatment Decisions and Accurate Detection of Hereditary Renal Cell Carcinomas
Journal: Aktuelle Urologie
Published: December 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Muller's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile